FREQUENCY OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) IN PATIENTS WITH METABOLIC SYNDROME. RMSR [Internet]. 2025 Mar. 20 [cited 2025 Aug. 18];3(3):812-8. Available from: https://www.medscireview.net/index.php/Journal/article/view/821